Understanding immune responses to develop vaccines for infectious diseases
NIH TETRAMER CORE FACILITY (INFECTIOUS DISEASES OTHER THAN HIV/AIDS)
['FUNDING_OTHER'] · EMORY UNIVERSITY · NIH-10376128
This study is all about learning how our immune system fights infections, which can help create better vaccines and treatments for everyone, especially those who get sick.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-10376128 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing our understanding of immune responses to infectious diseases, which is crucial for developing effective vaccines and therapies. The NIH Major Histocompatibility Complex (MHC) Tetramer Core Facility plays a key role by providing essential reagents that help researchers study how the immune system recognizes and responds to pathogens. By synthesizing and distributing MHC tetramer reagents, this facility supports a wide range of biomedical research aimed at improving public health outcomes related to infectious diseases. Patients may benefit indirectly through advancements in vaccine development and treatment options resulting from this research.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals affected by infectious diseases or those at risk of such diseases.
Not a fit: Patients with non-infectious diseases or conditions unrelated to immune responses may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines and therapies for various infectious diseases.
How similar studies have performed: Previous research utilizing MHC tetramer technology has shown promise in understanding immune responses and developing vaccines, indicating a successful track record for similar approaches.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ALTMAN, JOHN — EMORY UNIVERSITY
- Study coordinator: ALTMAN, JOHN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Infectious Disease Pathway, Infectious Diseases, Infectious Disorder, Communicable Diseases, Disorder